BIOMAT Database Logo BIOMAT Database Logo

Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease. 2021

Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, Quebec, Canada; Douglas Mental Health University Institute, Montreal, Quebec, Canada.

Major prevention trials for Alzheimer's disease (AD) are now focusing on multidomain lifestyle interventions. However, the exact combination of behavioral factors related to AD pathology remains unclear. In 2 cohorts of cognitively unimpaired individuals at risk of AD, we examined which combinations of personality traits, neuropsychiatric symptoms, and cognitive lifestyle (years of education or lifetime cognitive activity) related to the pathological hallmarks of AD, amyloid-β, and tau deposits. A total of 115 older adults with a parental or multiple-sibling family history of sporadic AD (PREVENT-AD [PRe-symptomatic EValuation of Experimental or Novel Treatments for AD] cohort) underwent amyloid and tau positron emission tomography and answered several questionnaires related to behavioral attributes. Separately, we studied 117 mutation carriers from the DIAN (Dominant Inherited Alzheimer Network) study group cohort with amyloid positron emission tomography and behavioral data. Using partial least squares analysis, we identified latent variables relating amyloid or tau pathology with combinations of personality traits, neuropsychiatric symptoms, and cognitive lifestyle. In PREVENT-AD, lower neuroticism, neuropsychiatric burden, and higher education were associated with less amyloid deposition (p = .014). Lower neuroticism and neuropsychiatric features, along with higher measures of openness and extraversion, were related to less tau deposition (p = .006). In DIAN, lower neuropsychiatric burden and higher education were also associated with less amyloid (p = .005). The combination of these factors accounted for up to 14% of AD pathology. In the preclinical phase of both sporadic and autosomal dominant AD, multiple behavioral features were associated with AD pathology. These results may suggest potential pathways by which multidomain interventions might help delay AD onset or progression.

UI MeSH Term Description Entries
D008019 Life Style Typical way of life or manner of living characteristic of an individual or group. (From APA, Thesaurus of Psychological Index Terms, 8th ed) Lifestyle Factors,Life Style Induced Illness,Lifestyle,Factor, Lifestyle,Life Styles,Lifestyle Factor,Lifestyles
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission

Related Publications

Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Association Between Visual Memory and In Vivo Amyloid and Tau Pathology in Preclinical Autosomal Dominant Alzheimer's Disease.
January 2021, Journal of the International Neuropsychological Society : JINS,
Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9.
October 2021, Molecular psychiatry,
Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer's disease.
August 2020, Alzheimer's research & therapy,
Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease.
April 2022, Proceedings of the National Academy of Sciences of the United States of America,
Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
April 2017, Alzheimer's & dementia : the journal of the Alzheimer's Association,
Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Differentiating amyloid beta spread in autosomal dominant and sporadic Alzheimer's disease.
January 2022, Brain communications,
Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease.
April 2021, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease.
March 2020, Journal of neurology, neurosurgery, and psychiatry,
Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
November 2017, Alzheimer's & dementia : the journal of the Alzheimer's Association,
Alexa Pichet Binette, and Étienne Vachon-Presseau, and John Morris, and Randall Bateman, and Tammie Benzinger, and D Louis Collins, and Judes Poirier, and John C S Breitner, and Sylvia Villeneuve, and , and
First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study.
May 2023, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!